| ARTICLE |
|
| Year : 2015 | Volume
: 14
| Issue : 4 | Page : 104-107 |
|
|
Retinal interventional management of blind painful and non-painful eyes at risk for neovascular glaucoma
Salman S Dar1, Alana L Grajewski2, Elena Bitrian3, Sandra R Montezuma1
1 University of Minnesota, Department of Ophthalmology
2 University of Minnesota, Department of Ophthalmology; University of Miami, Bascom Palmer Eye Institute
3 University of Minnesota, Department of Ophthalmology; Mayo Clinic, Department of Ophthalmology
Correspondence Address:
M.D Salman S Dar
130 S. Canal St, unit 614, Chicago, IL 60606
 Source of Support: None, Conflict of Interest: None
|
|
|
Purpose: To review standard management of blind painful and non-painful eyes at risk for neovascular glaucoma, and report the management strategies of four cases.
Method: Case series and literature review.
Patients: The first two cases described are blind, painful eyes secondary to neovascular glaucoma, treated with intracameral bevacizumab injections. The third case, a blind, painful eye with uncontrolled glaucoma in a patient unsatisfied with her eye appearance due to white retained lens material at pupillary margin and a large prominent bleb, was treated with a combination of bleb revision, vitrectomy, lensectomy and endocyclophotocoagulation. The fourth case, a blind, non-painful eye with secondary radiation retinopathy at risk for neovascular glaucoma was treated with laser photocoagulation to prevent neovascular glaucoma and pain.
Results: The first two cases of blind, painful eyes with neovascular glaucoma had reduction in neovascularization and pain after intracameral bevacizumab injections and/or laser therapy. The third case had resolution of pain and transient decrease in intraocular pressure after a combined surgery. The blind, non-painful eye in case 4 with a history of radiation retinopathy had stable intrao pressure and no progression to neovascular glaucoma or pain. None of the four cases progressed to enucleation or evisceration.
Discussion: Retinal interventional management should be considered in blind painful and non-painful eyes to help control symptoms, treat or prevent progression to neovascular glaucoma and prevention of enucleation or evisceration.
|
|
|
|
| [PDF]* |
|
 |
|
